We fund clinical trials for all types of cancers and prioritize only the most cutting-edge research that can help patients TODAY. Gateway invests in next generation patient-centric cancer research in order to drive transformational advances and breakthroughs in cancer treatment.
How Gateway is Unique:
Patients have a voice.
Helping cancer patients feel better and live longer.
Gateway invests in breakthrough research that is both targeted and precise.
99 cents of every dollar Gateway receives goes directly to fund Phase I and Phase II cancer clinical trials.
Jane Winter, MD & Bryan Locke, MD, Northwestern University
Phase II: Study of pidilizumab in patients with diffuse large B-cell lymphoma following first remission
FUND ONE DAY
Gateway only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen. Phase I and II clinical trials are severely underfunded, yet have the greatest patient impact in conquering cancer.
It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial. Will you help us fund another day of research? Fund one day, one week or more!
Gateway for Cancer Research is proud to announce a new scientific partnership with Conquer Cancer, the ASCO Foundation, establishing the Gateway Discovery Grant Program. This biennial grant will identify compelling areas of inquiry in early phase cancer research and fund the talented clinician-scientists best positioned to pursue them.